Clinical Trial Update: HIV Prevention for Injecting Drug Users in Kazakhstan [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial on HIV prevention among injecting drug users in Kazakhstan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Columbia University | Conditions: HIV, AIDS | Phase 2 | Status: COMPLETED